ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625505 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625505; 2) Community: the network communities that were significantly associated with the response to NSC 625505; 3) Molecule: the relationships between components within communities and NSC 625505; 4) MDR: the compounds that were significantly associated with the NSC 625505.

NSC Compound Enrichment Correlation
NSC 715229 Null 0.00479683626511385 0.38699039
NSC 732837 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-4-chloro-3-trifluoromethylbenzene 0.00479683626511385 0.32646531
NSC 743862 Null 0.00479683626511385 0.29522586
NSC 758682 ARTENIMOL 0.00479683626511385 0.29529785
NSC 102810 D-ARABINOSE, 5-O-TRITYL-TRIBENZOATE 0.00479683626511392 0.31542489
NSC 176503 Fastigilin B 0.00479683626511392 0.43217968
NSC 201459 1H-Indol-2-one, 5-bromo-2,3-dihydro-3-[[(4-methoxyphenyl) carbonyl]methylene]- 0.00645628049634952 0.33017111
NSC 248040 Null 0.00645628049634952 0.34068802
NSC 615441 1H-Dibenz[de,h]isoquinoline-1,3-dione, 2,2'- [(1,2-ethanediyldiamino)bis(1,3-propanediyl)] bis[2,3-dihydro-, dihydrochloride 0.00645628049634952 0.25143277
NSC 626880 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-hydroxy- phenyl)methylene]-, hydrochloride 0.00645628049634956 0.38769408
Total:118  Current:25    [First] [Prev] [Next] [Last]